$15.04
$0.17 (+1.14%)
$14.73Day Range$15.20
Key Statistics
Market Cap
$1.38B
Shares Outstanding
92.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 8, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$14.88
Day High
$15.20
Day Low
$14.73
Volume
671.6K
VWAP
$15.01
Prev Close
$14.87
Transactions
--
Acc. Volume
--
About Alpha Tau Medical Ltd. Ordinary Shares
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Identifiers
- CIK
- 0001871321
- Ticker Root
- DRTS
About Alpha Tau Medical Ltd. Ordinary Shares (DRTS) Stock
Alpha Tau Medical Ltd. Ordinary Shares (DRTS) closed the 2026-09-16 session at $15.04, up 1.14% versus the previous close (+0.17). The stock opened at $14.88 and traded between $14.73 and $15.20 during that session. Session trading volume was 672K shares. The volume-weighted average price (VWAP) is $15.01.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Alpha Tau Medical Ltd. Ordinary Shares has a market capitalization of $1.38 billion. DRTS is listed on the XNAS exchange. The company employs approximately 121 people. The recorded listing date is 2022-03-08.
On this page you can find market DRTS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.